| 前收盘价格 | 25.48 |
| 收盘价格 | 25.69 |
| 成交量 | 1,061,577 |
| 平均成交量 (3个月) | 1,845,871 |
| 市值 | 1,730,628,352 |
| 价格/销量 (P/S) | 8.35 |
| 股市价格/股市净资产 (P/B) | 6.65 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2026 |
| 营业毛利率 | -83.39% |
| 营业利益率 (TTM) | -85.45% |
| 稀释每股收益 (EPS TTM) | -2.63 |
| 季度收入增长率 (YOY) | 62.70% |
| 总债务/股东权益 (D/E MRQ) | 31.15% |
| 流动比率 (MRQ) | 3.45 |
| 营业现金流 (OCF TTM) | 25.97 M |
| 杠杆自由现金流 (LFCF TTM) | -17.73 M |
| 资产报酬率 (ROA TTM) | -16.27% |
| 股东权益报酬率 (ROE TTM) | -43.33% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 混合的 | 看跌 |
| Health Information Services (全球的) | 混合的 | 看跌 | |
| 股票 | Schrodinger, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -1.5 |
| 相对估值 | NA |
| 财务健康 | NA |
| AI Insight | NA |
| 平均 | -2.83 |
|
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Core |
| 内部持股比例 | 2.63% |
| 机构持股比例 | 101.76% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Gates Foundation Trust | 30 Jun 2026 | 6,981,664 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合